Rhythm Pharmaceuticals (RYTM) PT Raised to $95 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $95.00 (from $73.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
